Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Florida
| Provider | Medicare | Services |
|---|---|---|
| Biogroup Laboratory Corp | $38.52 | 4.0K |
| Apprise Diagnostics Llc | $38.52 | 3.0K |
| Hematopathology Associates Llc | $38.52 | 1.9K |
| Dynix Diagnostix | $38.52 | 1.6K |
| Clear Choice Diagnostics Inc | $38.52 | 1.4K |
| Pro Diametrics Corp | $38.49 | 1.3K |
| E-Lab Of Florida Inc. | $38.52 | 833 |
| Reliable Results Labs Inc | $38.52 | 724 |
| Southern Quest Llc | $38.52 | 578 |
| Prince Laboratories Limited... | $38.52 | 473 |
| Lab Diagnostics Llc | $38.52 | 324 |
| Spartan Laboratories Inc | $38.22 | 229 |
| Precheck Health Services Inc | $38.52 | 94 |
| Molecular Clinical Laboratory, Inc | $38.52 | 88 |
| Silverstardx Llc | $38.42 | 72 |
| Galatea Bio, Inc. | $38.52 | 67 |
| Express Gene Llc | $38.52 | 58 |
| Ideal Diagnostic | $38.52 | 45 |
| Mainstream Diagnostic Laboratory... | $38.52 | 43 |
| Analyze Pathology Inc. | $38.52 | 13 |
Florida Pricing in Context
In Florida, CPT code 81209 (Gene Analysis (bloom Syndrome, Recq Helicase-Like)) carries an average Medicare payment of $38.51 — 0% above the national benchmark of $38.51. 24 providers across the state submitted claims for this procedure in 2023, performing 16.7K total services. Individual payments in FL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Florida is $42.97, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Florida sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in Florida lands near $90.51, with self-pay cash prices typically around $40.70. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Gene Analysis (bloom Syndrome, Recq Helicase-Like) cost in Florida?
The average Medicare payment for Gene Analysis (bloom Syndrome, Recq Helicase-Like) in Florida is $38.51, which is 0% above the national average of $38.51. Providers in FL typically bill $42.97 for this procedure.
What does Gene Analysis (bloom Syndrome, Recq Helicase-Like) cost with insurance in Florida?
With commercial insurance in Florida, Gene Analysis (bloom Syndrome, Recq Helicase-Like) costs an estimated $90.51. Without insurance, the estimated cash price is $40.70. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Gene Analysis (bloom Syndrome, Recq Helicase-Like) in Florida?
24 providers in Florida billed Medicare for Gene Analysis (bloom Syndrome, Recq Helicase-Like) in 2023, performing 16.7K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Gene Analysis (bloom Syndrome, Recq Helicase-Like) cheaper in Florida than the national average?
No — Gene Analysis (bloom Syndrome, Recq Helicase-Like) costs 0% above the national average in Florida. The state average Medicare payment is $38.51 compared to $38.51 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.